Ashwagandha and Breast Cancer: What the Quality-of-Life Research Really Shows
One analysis ranked ashwagandha first for quality of life in breast cancer. It rests on one non-randomized trial. What it found and what it can’t tell you.
One analysis ranked ashwagandha first for quality of life in breast cancer. It rests on one non-randomized trial. What it found and what it can’t tell you.
PMS is cyclical and predictable, perimenopause is erratic and estrogen-driven. How to tell them apart, and why the distinction changes ashwagandha dosing.
Palpitations in perimenopause usually track estrogen and adrenaline, but thyroid is the ashwagandha-specific concern. When symptoms warrant medical review.
Price mostly reflects extract standardisation, plant part and third-party testing, not brand. What you are actually paying for in premium ashwagandha.
Vitamin D deficiency is common in midlife and affects mood and sleep independently. Whether pairing it with ashwagandha does anything the trials support.
Morning ashwagandha targets the cortisol awakening response, evening dosing targets sleep onset. How to choose by your dominant perimenopause symptom.
Perimenopausal joint pain tracks declining estrogen and rising inflammation. Where ashwagandha’s anti-inflammatory data applies, and where it does not.
Cortisol drives central fat storage, and perimenopause changes where weight settles. What ashwagandha’s body composition trials genuinely show.
Rhodiola targets acute fatigue and mental stamina, ashwagandha targets chronic cortisol load. Which adaptogen suits which midlife stress pattern.
Ashwagandha raises T3 and T4 in trials, which helps some thyroid patterns and harms others. What the evidence says for perimenopausal thyroid health.
Most ashwagandha side effects are dose-linked and reversible, chiefly gastrointestinal and sedative. How to manage them, and when to stop instead.
Organic and non-GMO certify farming practice, not withanolide content or heavy metal safety. What each label covers, and what it leaves out.